AC Immune (ACIU) Net Income (2015 - 2026)

AC Immune (ACIU) has 12 years of Net Income data on file, last reported at -$18.9 million in Q1 2026.

• On a quarterly basis, Net Income rose 10.7% year-over-year to -$18.9 million in Q1 2026; TTM through Mar 2026 was -$82.3 million, a 41.86% decrease from a year earlier, with the FY2025 full-year figure at -$85.0 million, down 46.19% from the prior year.
• Net Income for Q1 2026 stood at -$18.9 million, down from -$18.0 million in the prior quarter.
• Over the last five years, Net Income for ACIU reached as high as $6.4 million in Q3 2024 and fell as low as -$25.6 million in Q2 2025.
• Historically, Net Income has averaged -$17.4 million across 5 years, with a median of -$18.9 million in 2023.
• Across the five-year window, Net Income surged 137.05% in 2024 and slumped 412.07% in 2025, its largest moves.
• Year by year, Net Income stood at -$19.5 million in 2022, then jumped by 72.51% to -$5.3 million in 2023, then tumbled by 237.17% to -$18.0 million in 2024, then increased by 0.27% to -$18.0 million in 2025, then retreated by 5.1% to -$18.9 million in 2026.
• Per Business Quant data, the three most recent Net Income figures were -$18.9 million in Q1 2026, -$18.0 million in Q4 2025, and -$19.8 million in Q3 2025.